This site is intended for healthcare professionals
News

Adakveo receives positive CHMP opinion for the prevention of recurrent vaso-occlusive crises in patients with sickle cell disease.- Novartis

Read time: 1 mins
Last updated:27th Jul 2020
Published:25th Jul 2020
Condition: Sickle Cell Disease: Pain Crises
Type: drug
Register free for full access to medthority.com